News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
724,501 Results
Type
Article (48475)
Company Profile (309)
Press Release (675717)
Section
Business (210267)
Career Advice (2406)
Deals (36151)
Drug Delivery (113)
Drug Development (82726)
Employer Resources (192)
FDA (16431)
Job Trends (15321)
News (354502)
Policy (33501)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (4)
2024 BioForest Standard (1)
2024 BioMidwest Digital (10)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (10)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (20)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (8)
2024 Genetown Digital (6)
2024 Genetown Standard (12)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (7)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2783)
Academic (2)
Accelerated approval (4)
Adcomms (23)
Allergies (82)
Alliances (51435)
ALS (88)
Alzheimer's disease (1407)
Antibody-drug conjugate (ADC) (116)
Approvals (16425)
Artificial intelligence (254)
Autoimmune disease (16)
Automation (14)
Bankruptcy (366)
Best Places to Work (11889)
BIOSECURE Act (19)
Biosimilars (103)
Biotechnology (211)
Bladder cancer (60)
Brain cancer (24)
Breast cancer (251)
Cancer (2044)
Cardiovascular disease (168)
Career advice (2009)
Career pathing (32)
CAR-T (149)
Cell therapy (417)
Cervical cancer (20)
Clinical research (66715)
Collaboration (793)
Compensation (461)
Complete response letters (23)
COVID-19 (2680)
CRISPR (40)
C-suite (217)
Cystic fibrosis (99)
Data (1982)
Decentralized trials (2)
Denatured (29)
Depression (40)
Diabetes (251)
Diagnostics (6566)
Digital health (17)
Diversity (9)
Diversity, equity & inclusion (47)
Drug discovery (117)
Drug pricing (104)
Drug shortages (26)
Duchenne muscular dystrophy (88)
Earnings (87278)
Editorial (34)
Employer branding (25)
Employer resources (162)
Events (115860)
Executive appointments (664)
FDA (17559)
Featured Employer (54)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (716)
Gene editing (105)
Generative AI (21)
Gene therapy (299)
GLP-1 (737)
Government (4570)
Grass and pollen (4)
Guidances (49)
Healthcare (19309)
Huntington's disease (24)
IgA nephropathy (25)
Immunology and inflammation (109)
Indications (26)
Infectious disease (2814)
Inflammatory bowel disease (138)
Inflation Reduction Act (10)
Influenza (47)
Intellectual property (89)
Interviews (395)
IPO (16755)
IRA (42)
Job creations (3868)
Job search strategy (1706)
Kidney cancer (9)
Labor market (37)
Layoffs (480)
Leadership (18)
Legal (8132)
Liver cancer (72)
Lung cancer (301)
Lymphoma (135)
Machine learning (4)
Management (62)
Manufacturing (278)
MASH (63)
Medical device (13540)
Medtech (13545)
Mergers & acquisitions (19870)
Metabolic disorders (656)
Multiple sclerosis (72)
NASH (22)
Neurodegenerative disease (86)
Neuropsychiatric disorders (25)
Neuroscience (1905)
NextGen: Class of 2025 (6793)
Non-profit (4678)
Northern California (2460)
Now hiring (38)
Obesity (359)
Opinion (226)
Ovarian cancer (74)
Pain (82)
Pancreatic cancer (78)
Parkinson's disease (138)
Partnered (20)
Patents (207)
Patient recruitment (95)
Peanut (48)
People (59327)
Pharmaceutical (74)
Pharmacy benefit managers (18)
Phase I (20821)
Phase II (29354)
Phase III (21869)
Pipeline (1051)
Podcasts (63)
Policy (118)
Postmarket research (2658)
Preclinical (9061)
Press Release (72)
Prostate cancer (95)
Psychedelics (32)
Radiopharmaceuticals (250)
Rare diseases (368)
Real estate (6253)
Recruiting (73)
Regulatory (22779)
Reports (55)
Research institute (2513)
Resumes & cover letters (419)
Rett syndrome (4)
RNA editing (4)
RSV (41)
Schizophrenia (68)
Series A (127)
Series B (81)
Service/supplier (14)
Sickle cell disease (54)
Southern California (2135)
Special edition (15)
Spinal muscular atrophy (151)
Sponsored (30)
Startups (3799)
State (2)
Stomach cancer (14)
Supply chain (60)
The Weekly (32)
United States (21661)
Vaccines (690)
Venture capitalists (38)
Webinars (12)
Weight loss (243)
Women's health (35)
Worklife (17)
Date
Today (143)
Last 7 days (724)
Last 30 days (2805)
Last 365 days (34351)
2025 (8322)
2024 (36110)
2023 (41043)
2022 (52117)
2021 (56741)
2020 (55201)
2019 (47969)
2018 (36208)
2017 (33378)
2016 (33020)
2015 (39071)
2014 (32708)
2013 (27876)
2012 (30121)
2011 (30861)
2010 (29357)
Location
Africa (820)
Alabama (50)
Alaska (7)
Arizona (234)
Arkansas (14)
Asia (39826)
Australia (6609)
California (5629)
Canada (1879)
China (483)
Colorado (255)
Connecticut (258)
Delaware (129)
Europe (87183)
Florida (826)
Georgia (203)
Hawaii (1)
Idaho (58)
Illinois (515)
India (25)
Indiana (299)
Iowa (9)
Japan (143)
Kansas (102)
Kentucky (25)
Louisiana (8)
Maine (60)
Maryland (850)
Massachusetts (4265)
Michigan (226)
Minnesota (387)
Mississippi (2)
Missouri (78)
Montana (27)
Nebraska (25)
Nevada (57)
New Hampshire (64)
New Jersey (1612)
New Mexico (30)
New York (1624)
North Carolina (968)
North Dakota (8)
Northern California (2460)
Ohio (193)
Oklahoma (14)
Oregon (34)
Pennsylvania (1269)
Puerto Rico (9)
Rhode Island (26)
South America (1196)
South Carolina (18)
South Dakota (1)
Southern California (2135)
Tennessee (94)
Texas (840)
Utah (170)
Virginia (131)
Washington D.C. (62)
Washington State (528)
West Virginia (3)
Wisconsin (58)
724,501 Results for "applied dna sciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Applied DNA Announces 1-For-50 Reverse Stock Split Effective March 14, 2025
March 12, 2025
·
5 min read
Press Releases
Applied DNA Reminds Shareholders to Vote Ahead of Special Meeting on February 14
February 11, 2025
·
3 min read
Pharm Country
Applied DNA Announces Pricing of $12 Million Public Offering
Applied DNA Sciences, Inc., a leader in PCR-based DNA technologies, announced the pricing of a public offering with gross proceeds to the Company expected to be approximately $12.0 million, before deducting placement agent fees and other estimated expenses payable by the Company.
May 28, 2024
·
5 min read
Business
Applied DNA Announces Second Quarter Fiscal Year 2024 Financial Results
Applied DNA Sciences, Inc., a leader in PCR-based DNA technologies, announced consolidated financial results for its second fiscal quarter ended March 31, 2024.
May 10, 2024
·
11 min read
Deals
Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement
Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a leader in PCR-based DNA technologies, today announced that on May 9, 2024, it received a notification letter from the Listing Qualifications Department of the Nasdaq Stock Market informing the Company that it has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2).
May 10, 2024
·
3 min read
Pharm Country
Applied DNA Receives Approval for TR8(TM) Pharmacogenomic (PGx) Testing Service from New York State Department of Health
Applied DNA Sciences, Inc. (NASDAQ:APDN) (“Applied DNA” or the “Company”), a leader in PCR-based DNA technologies, today announced that the New York State Department of Health (“NYSDOH”) approved the Company’s TR8™ PGx (“TR8") pharmacogenomic (PGx) testing service.
June 13, 2024
·
5 min read
Press Releases
Applied DNA Reports First Quarter Fiscal 2025 Financial Results and Highlights Operational Progress
February 14, 2025
·
14 min read
Press Releases
Applied DNA Submits Validation Package to New York State Department of Health for H5 Bird Flu/Pan-Influenza A Laboratory-Developed Test
March 27, 2025
·
5 min read
Pharm Country
Applied DNA Partners with GenXys Health Care Systems to Deploy Clinical Decision Support System for Pharmacogenetic (PGx) Testing
Applied DNA Sciences, Inc. announced that its molecular diagnostics subsidiary, Applied DNA Clinical Labs, LLC, will utilize the GenXys Health Care Systems suite of clinical decision support software for interpretation and reporting of ADCL’s New York State Department of Health-approved TR8™ pharmacogenomic test.
June 18, 2024
·
5 min read
Press Releases
Applied DNA Completes Buildout of GMP Facility for LineaDNA IVT Templates
January 10, 2025
·
5 min read
1 of 72,451
Next